Plummer Nicholas

SEC source: 0001477932-26-001489 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 407,267

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 14,900 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-26-001145 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,270

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,483 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-26-001099 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420,137

F1 · shares: On February 26, 2026, the reporting person was awarded 187,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in twelve approximately equal monthly installments commencing on March 1, 2026. Once earned, they will remain subject to additional time-based vesting in a single installment on February 26, 2027, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the vesting date.

SEC source: 0001477932-26-000605 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,137

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,015 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-26-000361 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,784

F1 · shares: On March 17, 2025, the reporting person was awarded 149,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 44,700 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 14,900 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 104,300 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively.

SEC source: 0001477932-25-007901 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,084

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,016 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-25-007402 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,731

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 17,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-25-006098 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,877

F1 · shares: On August 15, 2025, the reporting person was awarded 24,031 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs will be earned in six approximately equal monthly installments commencing on September 1, 2025. Once earned, they will remain subject to additional time-based vesting in two installments of 12,016 units and 12,015 units on each of November 1, 2025 and February 1, 2026, respectively, and are generally subject to continued service by the reporting person throughout each applicable earning and vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have been earned and vested as of the applicable vesting date.

SEC source: 0001477932-25-005471 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,846

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 16,086 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-25-004917 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,297

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 11,527 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-25-004373 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC, Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,714

F1 · shares: On June 1, 2025, the reporting person was awarded 16,086 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 5,362 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001477932-25-001465 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,628

F1 · shares: On March 1, 2025, the reporting person was awarded 12,483 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 4,161 units on each of March 1, 2025, April 1, 2025 and May 1, 2025, respectively, are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001477932-24-007809 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC, Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,145

F1 · shares: On December 1, 2024, the reporting person was awarded 11,527 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,843 units, 3,842 units, and 3,842 units on each of December 1, 2024, January 1, 2025 and February 1, 2025, respectively, are also subject to further time-based vesting in a single installment on July 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001477932-24-006282 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC, Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,618

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 17,333 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-24-006100 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,764

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 15,525 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-24-005494 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,261

F1 · shares: On September 1, 2024, the reporting person was awarded 12,043 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 4,015 units, 4,014 units, and 4,014 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001477932-24-005033 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC, Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,218

F1 · shares: On Sept 28, 2023, the reporting person was awarded 69,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to Dec 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 17,250 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 5,750 units on each of Sept 28, 2024, 2025 and 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in Jan 2024, the rights with respect to 29,325 RSUs subject to the award previously vested and remain subject to time-based vesting. The rights with respect to the remaining 22,425 RSUs did not vest and were cancelled on August 15, 2024.

SEC source: 0001477932-24-003479 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,968

F1 · shares: On June 1, 2024, the reporting person was awarded 10,249 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 3,417 units, 3,416 units, and 3,416 units on each of June 1, 2024, July 1, 2024 and August 1, 2024, respectively, are also subject to further time-based vesting in a single installment on May 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001477932-24-000408 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,719

F1 · shares: On September 28, 2023, the reporting person was awarded 69,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2023 and June 30, 2024 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 29,325 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 9,775 units on each of September 28, 2024, September 28, 2025 and September 28, 2026, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001477932-23-005107 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,394

F1 · shares: On October 4, 2022, the reporting person was awarded 52,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 23,400 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 7,800 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. As reported in October 2022 and January 2023 respectively, the rights with respect to 9,100 RSUs and 19,500 RSUs subject to the award previously vested and remain subject to time-based vesting.

SEC source: 0001477932-23-000273 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,994

F1 · shares: On October 4, 2022, the reporting person was awarded 52,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 19,500 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 6,500 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 9,100 restricted stock units subject to the award previously vested and remain subject to time-based vesting.

SEC source: 0001477932-22-009221 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,494

SEC source: 0001477932-22-008141 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,694

F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 21,750 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

SEC source: 0001477932-22-007697 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,100

F1 · shares: On October 4, 2022, the reporting person was awarded 52,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 9,100 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three installments of 3,034 units, 3,033 units, and 3,033 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0001477932-21-007790 · form4.xml · nonDerivative · entry 1

Plummer Nicholas · CIK 0001880653 · GC - Volition Diagnostics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,500

F1 · shares: In connection with his employment as General Counsel of Volition Diagnostics UK Limited, Mr. Plummer received restricted stock units subject to a 2-year vesting schedule, vesting as to 21,750 units on each of 11/01/22 and 11/01/23, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.